| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0025-7125(03)00146-9 |
| P698 | PubMed publication ID | 15049582 |
| P2093 | author name string | Howard B Goldman | |
| Suzette E Sutherland | |||
| P2860 | cites work | Burch colposuspension: long-term results and review of published reports | Q33775856 |
| The pharmacological treatment of urinary incontinence. | Q33778812 | ||
| Conservative treatment of urge urinary incontinence in women: a systematic review of randomized clinical trials | Q33836037 | ||
| Hysterectomy and urinary incontinence: a systematic review | Q33914582 | ||
| Risk factors for urinary incontinence in women. | Q33928031 | ||
| Evaluation and diagnosis of the overactive bladder | Q34542599 | ||
| Drug therapy of urinary urge incontinence: a systematic review. | Q34992752 | ||
| Urinary incontinence associated with dementia | Q40608761 | ||
| Influence of behavior modification on overactive bladder | Q40614355 | ||
| Economic costs of urinary incontinence in 1995. | Q40866193 | ||
| Urodynamic effects of intravesical resiniferatoxin in humans: preliminary results in stable and unstable detrusor | Q40878055 | ||
| Behavioral intervention for community-dwelling individuals with urinary incontinence | Q41718439 | ||
| Urinary incontinence: does it increase risk for falls and fractures? Study of Osteoporotic Fractures Research Group | Q41747291 | ||
| Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder. | Q43542367 | ||
| Pharmacokinetics of the R- and S-enantiomers of oxybutynin and N-desethyloxybutynin following oral and transdermal administration of the racemate in healthy volunteers | Q43702215 | ||
| Duloxetine versus placebo in the treatment of stress urinary incontinence | Q44062087 | ||
| Obesity and lower urinary tract function in women: effect of surgically induced weight loss | Q44900699 | ||
| Cigarette smoking and pure genuine stress incontinence of urine: a comparison of risk factors and determinants between smokers and nonsmokers | Q45088817 | ||
| Caffeine: does it affect your bladder? | Q45107621 | ||
| Comparative efficacy of behavioral interventions in the management of female urinary incontinence. Continence Program for Women Research Group | Q45114417 | ||
| The association of diet and other lifestyle factors with overactive bladder and stress incontinence: a longitudinal study in women | Q46417258 | ||
| The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. | Q53317478 | ||
| Behavioral training with and without biofeedback in the treatment of urge incontinence in older women: a randomized controlled trial. | Q53408731 | ||
| Quality of life impact of urge incontinence in older persons: a new measure and conceptual structure. | Q53544304 | ||
| Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program in Women (CPW) Research Group. | Q53657266 | ||
| Behavioral vs Drug Treatment for Urge Urinary Incontinence in Older Women | Q56639150 | ||
| Determinants of vaginal-perineal integrity and pelvic floor functioning in childbirth | Q63616144 | ||
| The role of biofeedback in Kegel exercise training for stress urinary incontinence | Q70010015 | ||
| Efficacy of biofeedback, when included with pelvic floor muscle exercise treatment, for genuine stress incontinence | Q71230136 | ||
| Continence for women: a test of AWHONN's evidence-based protocol in clinical practice. Association of Women's Health Obstetric and Neonatal Nurses | Q73413269 | ||
| Long-term effectiveness of sacral nerve stimulation for refractory urge incontinence | Q73430798 | ||
| Parturition and urinary incontinence in primiparas | Q73588780 | ||
| Combined behavioral and drug therapy for urge incontinence in older women | Q73751257 | ||
| The association of depressive symptoms and urinary incontinence among older adults | Q73751289 | ||
| Intravesical capsaicin as a treatment for refractory detrusor hyperreflexia: a dual center study with long-term followup | Q73872828 | ||
| Long-term results of the tension-free vaginal tape (TVT) procedure for surgical treatment of female stress urinary incontinence | Q74193437 | ||
| Long-term results of the FemSoft urethral insert for the management of female stress urinary incontinence | Q74258351 | ||
| The risk of stress incontinence 5 years after first delivery | Q74307489 | ||
| Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder | Q74783033 | ||
| Physiologic therapy for urinary stress incontinence | Q75745557 | ||
| Pubovaginal fascial sling for all types of stress urinary incontinence: long-term analysis | Q77342250 | ||
| Body mass index and urinary symptoms in women | Q77501932 | ||
| A new intravaginal device for stress incontinence in women | Q77651870 | ||
| Progressive resistance exercise in the functional restoration of the perineal muscles | Q79458880 | ||
| The clinical use of urecholine in dysfunctions of the bladder | Q80367254 | ||
| Treatment of exercise incontinence with a urethral insert: a pilot study in women | Q82569333 | ||
| P433 | issue | 2 | |
| P921 | main subject | urinary incontinence | Q281490 |
| P304 | page(s) | 345-366 | |
| P577 | publication date | 2004-03-01 | |
| P1433 | published in | Medical Clinics of North America | Q15761972 |
| P1476 | title | Treatment options for female urinary incontinence | |
| P478 | volume | 88 |
| Q30457700 | Correlates among nocturnal agitation, sleep, and urinary incontinence in dementia |
| Q34244642 | Physiotherapy for women with stress urinary incontinence: a review article |
| Q37944507 | Sacral neuromodulation for lower urinary tract dysfunction |
| Q33670955 | The symptomatic management of multiple sclerosis |
Search more.